vs
Heritage Insurance Holdings, Inc.（HRTG）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Heritage Insurance Holdings, Inc.的1.5倍（$321.1M vs $215.3M），Heritage Insurance Holdings, Inc.净利率更高（31.0% vs -18.2%，领先49.2%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 2.4%），Heritage Insurance Holdings, Inc.自由现金流更多（$174.2M vs $-133.8M）
该公司是一家位于美国佛罗里达州的财产意外保险公司，在美国多个沿海州开展业务，主要为客户提供商业保险、住宅保险、房主保险以及洪水保险等各类财产意外保障产品。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
HRTG vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.5倍
$215.3M
营收增速更快
MDGL
高出208.4%
2.4%
净利率更高
HRTG
高出49.2%
-18.2%
自由现金流更多
HRTG
多$308.0M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $215.3M | $321.1M |
| 净利润 | $66.7M | $-58.6M |
| 毛利率 | — | — |
| 营业利润率 | 41.6% | -18.6% |
| 净利率 | 31.0% | -18.2% |
| 营收同比 | 2.4% | 210.8% |
| 净利润同比 | 228.6% | 1.4% |
| 每股收益（稀释后） | $2.15 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRTGMDGL
| Q4 25 | $215.3M | $321.1M | ||
| Q3 25 | $212.5M | $287.3M | ||
| Q2 25 | $208.0M | $212.8M | ||
| Q1 25 | $211.5M | $137.3M | ||
| Q4 24 | $210.3M | $103.3M | ||
| Q3 24 | $211.8M | $62.2M | ||
| Q2 24 | $203.6M | — | ||
| Q1 24 | $191.3M | $0 |
净利润HRTGMDGL
| Q4 25 | $66.7M | $-58.6M | ||
| Q3 25 | $50.4M | $-114.2M | ||
| Q2 25 | $48.0M | $-42.3M | ||
| Q1 25 | $30.5M | $-73.2M | ||
| Q4 24 | $20.3M | $-59.4M | ||
| Q3 24 | $8.2M | $-107.0M | ||
| Q2 24 | $18.9M | — | ||
| Q1 24 | $14.2M | $-147.5M |
毛利率HRTGMDGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 96.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率HRTGMDGL
| Q4 25 | 41.6% | -18.6% | ||
| Q3 25 | 33.0% | -39.7% | ||
| Q2 25 | 31.2% | -22.2% | ||
| Q1 25 | 20.1% | -57.8% | ||
| Q4 24 | 15.0% | -64.8% | ||
| Q3 24 | 5.5% | -187.1% | ||
| Q2 24 | 13.6% | — | ||
| Q1 24 | 11.9% | — |
净利率HRTGMDGL
| Q4 25 | 31.0% | -18.2% | ||
| Q3 25 | 23.7% | -39.8% | ||
| Q2 25 | 23.1% | -19.9% | ||
| Q1 25 | 14.4% | -53.4% | ||
| Q4 24 | 9.7% | -57.5% | ||
| Q3 24 | 3.8% | -172.0% | ||
| Q2 24 | 9.3% | — | ||
| Q1 24 | 7.4% | — |
每股收益（稀释后）HRTGMDGL
| Q4 25 | $2.15 | $-2.55 | ||
| Q3 25 | $1.63 | $-5.08 | ||
| Q2 25 | $1.55 | $-1.90 | ||
| Q1 25 | $0.99 | $-3.32 | ||
| Q4 24 | $0.66 | $-2.50 | ||
| Q3 24 | $0.27 | $-4.92 | ||
| Q2 24 | $0.61 | — | ||
| Q1 24 | $0.47 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $559.3M | $198.7M |
| 总债务越低越好 | $78.4M | $339.9M |
| 股东权益账面价值 | $505.3M | $602.7M |
| 总资产 | $2.2B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资HRTGMDGL
| Q4 25 | $559.3M | $198.7M | ||
| Q3 25 | $560.4M | $295.7M | ||
| Q2 25 | $473.5M | $186.2M | ||
| Q1 25 | $425.9M | $183.6M | ||
| Q4 24 | $452.7M | $100.0M | ||
| Q3 24 | $509.9M | $232.7M | ||
| Q2 24 | $480.9M | — | ||
| Q1 24 | $386.1M | $622.5M |
总债务HRTGMDGL
| Q4 25 | $78.4M | $339.9M | ||
| Q3 25 | $79.3M | $339.8M | ||
| Q2 25 | $92.4M | $118.4M | ||
| Q1 25 | $94.8M | $118.0M | ||
| Q4 24 | $116.3M | $117.6M | ||
| Q3 24 | $118.6M | $117.1M | ||
| Q2 24 | $120.8M | — | ||
| Q1 24 | $123.0M | $116.1M |
股东权益HRTGMDGL
| Q4 25 | $505.3M | $602.7M | ||
| Q3 25 | $437.3M | $625.7M | ||
| Q2 25 | $383.3M | $696.0M | ||
| Q1 25 | $329.0M | $710.6M | ||
| Q4 24 | $290.8M | $754.4M | ||
| Q3 24 | $279.3M | $777.2M | ||
| Q2 24 | $255.3M | — | ||
| Q1 24 | $234.9M | $850.8M |
总资产HRTGMDGL
| Q4 25 | $2.2B | $1.3B | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $2.5B | $1.0B | ||
| Q1 25 | $2.2B | $996.6M | ||
| Q4 24 | $2.5B | $1.0B | ||
| Q3 24 | $2.4B | $1.1B | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.1B | $1.1B |
负债/权益比HRTGMDGL
| Q4 25 | 0.16× | 0.56× | ||
| Q3 25 | 0.18× | 0.54× | ||
| Q2 25 | 0.24× | 0.17× | ||
| Q1 25 | 0.29× | 0.17× | ||
| Q4 24 | 0.40× | 0.16× | ||
| Q3 24 | 0.42× | 0.15× | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.52× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $182.2M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $174.2M | $-133.8M |
| 自由现金流率自由现金流/营收 | 80.9% | -41.7% |
| 资本支出强度资本支出/营收 | 3.7% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.73× | — |
| 过去12个月自由现金流最近4个季度 | $337.4M | — |
8季度趋势，按日历期对齐
经营现金流HRTGMDGL
| Q4 25 | $182.2M | $-133.5M | ||
| Q3 25 | $124.3M | $79.8M | ||
| Q2 25 | $43.3M | $-47.1M | ||
| Q1 25 | $837.0K | $-88.9M | ||
| Q4 24 | $87.1M | $-104.5M | ||
| Q3 24 | $-13.4M | $-67.0M | ||
| Q2 24 | $152.2M | — | ||
| Q1 24 | $4.3M | $-149.2M |
自由现金流HRTGMDGL
| Q4 25 | $174.2M | $-133.8M | ||
| Q3 25 | $122.7M | $79.0M | ||
| Q2 25 | $41.8M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $78.9M | $-104.7M | ||
| Q3 24 | $-16.3M | $-67.8M | ||
| Q2 24 | $149.8M | — | ||
| Q1 24 | $4.1M | $-149.5M |
自由现金流率HRTGMDGL
| Q4 25 | 80.9% | -41.7% | ||
| Q3 25 | 57.8% | 27.5% | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | -0.6% | — | ||
| Q4 24 | 37.5% | -101.3% | ||
| Q3 24 | -7.7% | -109.0% | ||
| Q2 24 | 73.6% | — | ||
| Q1 24 | 2.1% | — |
资本支出强度HRTGMDGL
| Q4 25 | 3.7% | 0.1% | ||
| Q3 25 | 0.7% | 0.3% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 1.0% | 0.0% | ||
| Q4 24 | 3.9% | 0.2% | ||
| Q3 24 | 1.4% | 1.3% | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.1% | — |
现金转化率HRTGMDGL
| Q4 25 | 2.73× | — | ||
| Q3 25 | 2.47× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | -1.64× | — | ||
| Q2 24 | 8.07× | — | ||
| Q1 24 | 0.30× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRTG
暂无分部数据
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
